Product: Kushim Tablets (Gushim) 45-count packages, Label in foreign language
Reason for recall: Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine
Recall initiated: 20200128
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated